Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 1.86M | $17.0M | 19.73% | -- | 2026-06-30 |
| ADAR1 Capital Management, LLC | 777.1K | $7.0M | 8.25% | +49.6K | 2026-06-30 |
| ACORN CAPITAL ADVISORS, LLC | 634.5K | $5.0M | 6.73% | -- | 2026-06-30 |
| TCG Crossover Management, LLC | 464.4K | $4.0M | 4.93% | -- | 2026-06-30 |
| Commodore Capital LP | 464.4K | $4.0M | 4.93% | -- | 2026-06-30 |
| NEA Management Company, LLC | 464.4K | $4.0M | 4.93% | -- | 2026-06-30 |
| Spruce Street Capital LP | 393.7K | $3.0M | 4.18% | -- | 2026-06-30 |
| Kalehua Capital Management LLC | 393.7K | $3.0M | 4.18% | -- | 2026-06-30 |
| Blackstone Inc. | 324.6K | $2.0M | 3.45% | -- | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300.0K | $2.0M | 3.18% | -- | 2026-06-30 |
